1.16
price up icon1.75%   0.02
after-market 시간 외 거래: 1.18 0.02 +1.72%
loading
전일 마감가:
$1.14
열려 있는:
$1.17
하루 거래량:
269.07K
Relative Volume:
0.25
시가총액:
$17.49M
수익:
-
순이익/손실:
$-11.24M
주가수익비율:
-1.5233
EPS:
-0.7615
순현금흐름:
$-4.79M
1주 성능:
+11.54%
1개월 성능:
+22.36%
6개월 성능:
-38.95%
1년 성능:
+43.58%
1일 변동 폭
Value
$1.10
$1.19
1주일 범위
Value
$0.95
$1.21
52주 변동 폭
Value
$0.51
$5.01

Mira Pharmaceuticals Inc Stock (MIRA) Company Profile

Name
명칭
Mira Pharmaceuticals Inc
Name
전화
813-369-5150
Name
주소
1200 BRICKELL AVENUE, MIAMI
Name
직원
5
Name
트위터
Name
다음 수익 날짜
Name
최신 SEC 제출 서류
Name
MIRA's Discussions on Twitter

MIRA을(를) 다른 주식과 비교

주식 가격 시가총액 매출 순이익 현금흐름 주당 순 이익
Drug Manufacturers - General icon
MIRA
Mira Pharmaceuticals Inc
1.16 17.49M 0 -11.24M -4.79M -0.7615
Drug Manufacturers - General icon
LLY
Lilly Eli Co
823.62 713.24B 45.04B 10.59B 414.30M 11.71
Drug Manufacturers - General icon
JNJ
Johnson Johnson
156.12 370.90B 89.33B 21.81B 18.57B 8.99
Drug Manufacturers - General icon
ABBV
Abbvie Inc
198.47 329.14B 57.37B 4.20B 17.83B 2.35
Drug Manufacturers - General icon
NVO
Novo Nordisk Adr
69.23 275.58B 42.09B 14.65B 10.11B 3.2833
Drug Manufacturers - General icon
NVS
Novartis Ag Adr
114.29 221.49B 53.22B 12.86B 14.85B 6.39

Mira Pharmaceuticals Inc 주식(MIRA)의 최신 뉴스

pulisher
Apr 27, 2025

Weekly Roundup on the Cannabis Sector & Psychedelic Sector - marketexclusive.com

Apr 27, 2025
pulisher
Apr 24, 2025

Mira Pharmaceuticals Inc [MIRA] moved up 7.08: Why It’s Important - dbtnews.com

Apr 24, 2025
pulisher
Apr 24, 2025

Financial Metrics Unveiled: Mira Pharmaceuticals Inc (MIRA)’s Key Ratios in the Spotlight - DWinneX

Apr 24, 2025
pulisher
Apr 23, 2025

MIRA Pharmaceuticals reports positive in vitro drug release data for topical Ketamir-2 - MSN

Apr 23, 2025
pulisher
Apr 23, 2025

Mira Pharmaceuticals announces key drug development milestone By Investing.com - Investing.com Canada

Apr 23, 2025
pulisher
Apr 23, 2025

Mira Pharmaceuticals announces key drug development milestone - Investing.com Australia

Apr 23, 2025
pulisher
Apr 23, 2025

MIRA Pharmaceuticals (MIRA) Advances Ketamir-2 Formulations in P - GuruFocus

Apr 23, 2025
pulisher
Apr 23, 2025

MIRA Pharmaceuticals reports positive Ketamir-2 study By Investing.com - Investing.com India

Apr 23, 2025
pulisher
Apr 23, 2025

MIRA Pharmaceuticals reports positive Ketamir-2 study - Investing.com

Apr 23, 2025
pulisher
Apr 23, 2025

MIRA Pharmaceuticals Reports Positive In Vitro Drug Release Data for Topical Ketamir-2, Targeting $11B+ U.S. Topical Pain Relief Market and Exploring FDA Fast Track Designation - Weatherford Democrat

Apr 23, 2025
pulisher
Apr 23, 2025

Press Release Distribution & PR Platform - ACCESS Newswire

Apr 23, 2025
pulisher
Apr 23, 2025

MIRA's Novel Pain Treatment Delivers Positive Data, Targets Massive $11.5B Market With Fast-Track Potential - Stock Titan

Apr 23, 2025
pulisher
Apr 22, 2025

Mira Pharmaceuticals Inc (MIRA) is a good investment, but the stock may be undervalued - uspostnews.com

Apr 22, 2025
pulisher
Apr 21, 2025

MIRA’s Stock Market Odyssey: A Year of Growth, Decline, and Resilience - investchronicle.com

Apr 21, 2025
pulisher
Apr 18, 2025

Promising Canadian Stocks To Follow Now – April 16th - Defense World

Apr 18, 2025
pulisher
Apr 17, 2025

Is Mira Pharmaceuticals Gaining or Losing Market Support? - Benzinga

Apr 17, 2025
pulisher
Apr 16, 2025

US Health Care Stocks Face Mixed Results With Sector's Broad Decline - Finimize

Apr 16, 2025
pulisher
Apr 16, 2025

Pharmaceutical Stock Jumps After Key Trial Findings - MSN

Apr 16, 2025
pulisher
Apr 16, 2025

MIRA reports Ketamir-2 shows promise in diabetic neuropathy study By Investing.com - Investing.com South Africa

Apr 16, 2025
pulisher
Apr 16, 2025

Mira Says Diabetes Treatment Ketamir-2 Shows Significant Reduction in Neuropathic Pain Symptoms in Animal Model - marketscreener.com

Apr 16, 2025
pulisher
Apr 16, 2025

MIRA reports Ketamir-2 shows promise in diabetic neuropathy study - Investing.com Australia

Apr 16, 2025
pulisher
Apr 16, 2025

MIRA Pharmaceuticals reports positive Ketamir-2 study results - Investing.com

Apr 16, 2025
pulisher
Apr 16, 2025

MIRA Pharmaceuticals reports positive Ketamir-2 study results By Investing.com - Investing.com Canada

Apr 16, 2025
pulisher
Apr 16, 2025

MIRA Pharmaceuticals Announces Positive Results for Ketamir-2 in Diabetic Neuropathy Animal Model, Reinforcing Confidence Ahead of Phase I Completion - standard-journal.com

Apr 16, 2025
pulisher
Apr 16, 2025

Game-Changing Results: New Oral Ketamine Drug Outperforms FDA-Approved Pain Medications - Stock Titan

Apr 16, 2025
pulisher
Apr 16, 2025

Mira Pharmaceuticals IncAnnounces Positive Study Results For Ketamir-2 - marketscreener.com

Apr 16, 2025
pulisher
Apr 16, 2025

EXCLUSIVE: MIRA Pharmaceuticals Ketamir-2 Shows Efficacy In Diabetes-Associated Nerve Damage In Animal Study - Benzinga

Apr 16, 2025
pulisher
Apr 16, 2025

Mira Pharmaceuticals Inc’s Mixed Bag: Down -0.91% in 6 Months, Down -9.38% in 30 Days - investchronicle.com

Apr 16, 2025
pulisher
Apr 12, 2025

Mira Pharmaceuticals faces Nasdaq delisting over equity - Investing.com Australia

Apr 12, 2025
pulisher
Apr 11, 2025

Mira Pharmaceuticals faces Nasdaq delisting over equity By Investing.com - Investing.com South Africa

Apr 11, 2025
pulisher
Apr 04, 2025

MIRA Mira Pharmaceuticals files $100M mixed securities shelf - MSN

Apr 04, 2025
pulisher
Apr 04, 2025

Equities Analysts Issue Forecasts for MIRA FY2026 Earnings - Defense World

Apr 04, 2025
pulisher
Apr 01, 2025

MIRA Pharmaceuticals begins Phase 1 trial for pain treatment - Investing.com Australia

Apr 01, 2025
pulisher
Apr 01, 2025

MIRA Pharmaceuticals begins Phase 1 trial for pain treatment By Investing.com - Investing.com Philippines

Apr 01, 2025
pulisher
Apr 01, 2025

MIRA Pharmaceuticals Enrolls First Subjects in Phase 1 Clinical Trial of Ketamir-2 for Neuropathic Pain - guardonline.com

Apr 01, 2025
pulisher
Apr 01, 2025

Game-Changing Pain Treatment Enters Clinical Trials: Superior to Current Options in Early Data - Stock Titan

Apr 01, 2025
pulisher
Apr 01, 2025

63,410 Shares in MIRA Pharmaceuticals, Inc. (NASDAQ:MIRA) Purchased by Virtu Financial LLC - Defense World

Apr 01, 2025
pulisher
Mar 31, 2025

MIRA Pharmaceuticals (MIRA) Expected to Announce Earnings on Monday - Defense World

Mar 31, 2025
pulisher
Mar 31, 2025

MIRA Pharmaceuticals, Inc. (NASDAQ:MIRA) Short Interest Up 38.9% in March - Defense World

Mar 31, 2025
pulisher
Mar 28, 2025

MIRA Pharmaceuticals Inc. (MIRA) reports earnings - Quartz

Mar 28, 2025
pulisher
Mar 28, 2025

MIRA Pharmaceuticals (NASDAQ:MIRA) Stock Price Down 4.3% – Here’s What Happened - Defense World

Mar 28, 2025
pulisher
Mar 24, 2025

MIRA bids for SKNY - The Pharma Letter

Mar 24, 2025

Mira Pharmaceuticals Inc (MIRA) 재무 분석

매출

loading

순이익

loading

현금흐름

loading

주당 순 이익

loading
drug_manufacturers_general SNY
$55.44
price up icon 2.48%
$103.68
price up icon 0.42%
drug_manufacturers_general PFE
$24.20
price up icon 1.13%
$281.22
price down icon 0.90%
drug_manufacturers_general MRK
$83.18
price down icon 0.10%
drug_manufacturers_general NVS
$114.29
price up icon 2.66%
자본화:     |  볼륨(24시간):